A ‘state-of-the-art’ cancer care facility in Guildford has reached practical completion. Representatives from Prime, VINCI Building, and Assura, gathered ‘to mark the milestone’.
Spanning 24,300 ft2, the £30.5 million centre will offer advanced oncology treatments, and patients with cancer will have access to the latest treatment options – including highly targeted radiotherapy using a MRI linear accelerator (MR Linac), and Theranostics – ‘an innovative, personalised treatment that combines diagnostic imaging and radionuclide therapy to seek and destroy advanced cancers without damaging healthy tissue’.
Alongside offering advanced cancer treatments to private patients, the centre will offer some NHS patients access to technology not currently available on the NHS.
Phil Holland, Chief Investment officer at Prime, said: “This project has been a testament to the collaborative efforts of our dedicated team, who are committed to constructing a world-class facility that will make a meaningful difference in the lives of cancer patients and their families.”
Jason Griffiths, VINCI Building’s Regional director, said: “VINCI Building is delighted to have successfully delivered the Guildford Cancer Centre, and we are so proud to have been a part of the scheme. The delivery of this amazing project has been the culmination of great teamwork and vision, and this facility will change the lives of so many people in Surrey.”
The installation of advanced medical equipment with the new facility is now reaching final stages, with a grand opening scheduled for early 2024.
